Pancreatic cancer is relatively uncommon but disproportionately deadly, and certain groups face a significantly higher chance of developing it. The average lifetime risk is about 1 in 56 for men and 1 in 60 for women. Most cases are diagnosed later in life, with a median age of 71, and nearly 70% of diagnoses occur after age 65. But age is only one piece of the picture. Smoking history, body weight, diabetes status, family history, and even workplace chemical exposures all shift your individual risk.
Age and Sex
Pancreatic cancer is overwhelmingly a disease of older adults. Only about 10% of cases are diagnosed before age 55. The bulk of diagnoses cluster between 65 and 84, with that age range accounting for nearly 58% of all new cases. After 84, another 11.5% of cases are diagnosed. Cases in people under 35 are extremely rare, making up less than 1% of the total.
Men have a slightly higher lifetime risk than women (1 in 56 versus 1 in 60), though the reasons aren’t entirely clear. Higher historical rates of smoking and occupational chemical exposure among men likely contribute.
Smoking and How Quitting Helps
Smoking is the single most significant modifiable risk factor. Heavy smokers with a 50 pack-year history (the equivalent of a pack a day for 50 years, or two packs a day for 25 years) face a 91% increased risk compared to people who have never smoked. That’s nearly double the baseline risk.
The encouraging finding is that quitting makes a real difference. For every year after quitting, the excess risk from prior smoking drops by roughly 9%. After about 10 years of not smoking, risk decreases considerably. It doesn’t fully reset to a never-smoker’s level, especially for very heavy smokers, but the trajectory is clearly in the right direction.
Diabetes, Especially New Diagnoses
The relationship between diabetes and pancreatic cancer runs in both directions. Long-standing type 2 diabetes roughly doubles your risk of pancreatic cancer compared to the general population. But a new diabetes diagnosis carries a much sharper signal: new-onset diabetes triples the risk, and diabetes diagnosed within one year of a cancer finding increases it sevenfold.
This isn’t because diabetes itself always causes the cancer. In many cases, a growing pancreatic tumor disrupts insulin production, triggering diabetes 24 to 36 months before the cancer is detected. This type of diabetes frequently resolves after the tumor is surgically removed. For this reason, clinicians pay close attention when someone over 50 develops diabetes unexpectedly, particularly without the typical risk factors like obesity or family history of diabetes.
Obesity and Physical Activity
People with a BMI of 30 or higher face approximately double the risk of pancreatic cancer compared to those with a normal BMI (under 25). This effect holds for both men and women. Excess body fat promotes chronic low-grade inflammation and alters hormone levels in ways that can encourage cancer development in the pancreas.
The data on physical activity is more nuanced. In one large U.S. cohort study, moderate physical activity was linked to a 26% reduction in pancreatic cancer incidence compared to little or no activity. Interestingly, the highest levels of activity didn’t show additional benefit beyond moderate exercise. Staying reasonably active appears helpful, but extreme exercise doesn’t seem to offer extra protection for this particular cancer.
Chronic Pancreatitis
Chronic pancreatitis, a condition where the pancreas is persistently inflamed, carries a roughly threefold increased risk of pancreatic cancer even after accounting for shared risk factors like alcohol use and smoking. Over a 20-year period, an estimated 5% of people with chronic pancreatitis will develop pancreatic cancer.
The risk climbs dramatically for people who have both chronic pancreatitis and diabetes, with one study finding a combined hazard ratio of about 33 compared to the general population. A specific form called tropical pancreatitis, more common in parts of South Asia and sub-Saharan Africa, has been associated with a risk as high as 100 times that of people without the condition.
Genetic and Hereditary Factors
Roughly 4 to 7% of pancreatic cancers involve inherited mutations in the BRCA1 or BRCA2 genes, the same genes linked to breast and ovarian cancer. BRCA2 mutations are more common in pancreatic cancer specifically, found in 5 to 17% of familial cases, and they increase the risk by 3.5 to 10 times. Other inherited conditions that raise risk include Lynch syndrome, Peutz-Jeghers syndrome, and mutations in the CDKN2A gene (which also raises melanoma risk).
Having a first-degree relative with pancreatic cancer is itself a recognized risk factor. When two or more genetically related family members have had it, the risk is high enough that medical guidelines recommend formal screening. More recently, mutations in the NOD2 gene have drawn attention. One study found that a specific NOD2 variant nearly tripled the risk of pancreatic cancer.
When Screening Is Recommended
The American Gastroenterological Association recommends that high-risk individuals begin pancreatic cancer screening at age 50, or 10 years before the youngest age at which a family member was diagnosed. For people with CDKN2A mutations or hereditary pancreatitis, screening starts at 40. Those with Peutz-Jeghers syndrome should begin at 35. Screening typically involves imaging with MRI or endoscopic ultrasound rather than blood tests, since no reliable blood-based screening exists for the general population.
Workplace Chemical Exposures
Certain occupational exposures are linked to higher rates of pancreatic cancer. Regular exposure to benzene increases the odds by about 70%. Chlorinated hydrocarbons, a broad class of chemicals found in industrial solvents, pesticides, and plastics manufacturing, raise the odds by roughly 63%. Asbestos exposure is associated with a 54% increase, and regular pesticide exposure with a 21% increase.
Chlorinated hydrocarbons are particularly widespread. This chemical family includes compounds used in dry cleaning (tetrachloroethylene), metal degreasing (trichloroethylene), and various manufacturing processes. Workers in agriculture, chemical manufacturing, and metalworking may face elevated exposure. The data on chromium and nickel exposure is suggestive but not yet statistically conclusive.
Factors You Can and Cannot Change
The risk factors for pancreatic cancer fall into two clear groups. Age, sex, family history, and inherited gene mutations are outside your control. These are the factors that determine whether you might benefit from early surveillance programs.
Smoking, body weight, and chemical exposures are the levers you can actually pull. Quitting smoking produces measurable risk reduction within a decade. Maintaining a healthy weight cuts risk roughly in half compared to obesity. Moderate regular physical activity appears protective. For people who work around industrial chemicals, proper protective equipment and exposure reduction matter. None of these eliminate risk entirely, but together they represent the most meaningful steps available for lowering your chances.